Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives - a key step toward opening a fall booster campaign.
from The Washington Times stories: Health https://ift.tt/tJcS85r
from The Washington Times stories: Health https://ift.tt/tJcS85r